30 October 2018
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL. PLEASE SEE THE SECTION ENTITLED "DISCLAIMER" TOWARDS THE END OF THIS ANNOUNCEMENT.
This announcement is an advertisement for the purposes of the Prospectus Rules of the UK Financial Conduct Authority ("FCA") and does not constitute a prospectus. Investors must subscribe for or purchase any shares referred to in this announcement pursuant to the share issuance programme referred to below only on the basis of information contained in a prospectus expected to be published in due course by BB Healthcare Trust plc (the "Prospectus") in its final form and not in reliance on this announcement. A copy of the Prospectus will, following publication, be available for inspection from the Company's registered office and on its website (www.bbhealthcaretrust.com). This announcement does not constitute, and may not be construed as, an offer to sell or an invitation or recommendation to purchase, sell or subscribe for any securities or investments of any description, or a recommendation regarding the issue or the provision of investment advice by any party.
BB Healthcare Trust plc
Intention to Publish Prospectus
Further to BB Healthcare Trust plc's (the "Company's") announcement in February 2018 that it was investigating the possibility of publishing a prospectus, containing a new placing programme, the Board of the Company announces that it has instructed the Company's advisers to make arrangements for the publication of a new prospectus by the Company later this year, in order to facilitate the issuance of further Ordinary Shares pursuant to an Initial Issue and a share issuance programme in 2018 and beyond. The Company's portfolio manager, Bellevue Asset Management AG, continues to see significant opportunities to deploy additional capital, in accordance with the Company's investment objective and policy, and the Company has issued a further 52.2 million Ordinary Shares to date in 2018.
The Company will release further details in due course.
The Company's LEI is: 213800HQ3J3H9YF2UI82
Enquiries:
Bellevue Advisors Limited
Claude Mikkelsen
Telephone: +44 (0) 203 326 2983
Mobile: +44 (0) 755 704 8577
PraxisIFM Fund Services (UK) Limited
Anthony Lee / Ciara McKillop
+44 (0)20 7653 9690
Disclaimer
This announcement does not constitute a prospectus relating to the Company and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company in any jurisdiction nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract therefor.
The shares of the Company have not been and will not be registered under the US Securities Act of 1933, and may not be offered or sold in the United States. Outside the United States, the shares may be sold to non-US Persons pursuant to the provisions of Regulation S. Moreover, the shares of the Company have not been, nor will they be, registered under the applicable securities laws of Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom). Further, the Company will not be registered under the US Investment Company Act of 1940, as amended. Subject to certain exceptions, the shares of the Company may not be offered or sold in the United States, Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom or to professional investors in the Republic of Ireland, Denmark, Sweden, the Netherlands or Luxembourg) or to, or for the account or benefit of, any national, resident or citizen of the United States, Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom or professional investors in the Republic of Ireland, Denmark, Sweden, the Netherlands or Luxembourg). The share issuance programme, and the distribution of this announcement, in other jurisdictions may be restricted by law and the persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.
